Oct
02
2024
SAN DIEGO — Managing systemic inflammation is critical to reducing cardiovascular and pulmonary outcomes in patients with rheumatoid arthritis, according to a presenter at the 2024 Congress of Clinical Rheumatology West.
“Systemic inflammation is really an important risk factor for all kinds of comorbidities that we see,” Anja Strangfeld, MD, professor of epidemiology and health services research at the Charité – University Medicine Berlin and the German Rheumatism Research Center Berlin, told attendees.
Strangfeld presented findings on comorbidities and outcomes in RA
Read More
From Healio.com CARDIOLOGY •
•
